Download Citation
Article Source:
ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
Damaj G,
Joris M,
Chandesris O,
Hanssens K,
Soucie E,
et al.
(2014)
ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases.
PLOS ONE 9(1): e85362.
https://doi.org/10.1371/journal.pone.0085362